308 related articles for article (PubMed ID: 33882988)
1. Beyond association: successes and challenges in linking non-coding genetic variation to functional consequences that modulate Alzheimer's disease risk.
Novikova G; Andrews SJ; Renton AE; Marcora E
Mol Neurodegener; 2021 Apr; 16(1):27. PubMed ID: 33882988
[TBL] [Abstract][Full Text] [Related]
2. Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.
Novikova G; Kapoor M; Tcw J; Abud EM; Efthymiou AG; Chen SX; Cheng H; Fullard JF; Bendl J; Liu Y; Roussos P; Björkegren JL; Liu Y; Poon WW; Hao K; Marcora E; Goate AM
Nat Commun; 2021 Mar; 12(1):1610. PubMed ID: 33712570
[TBL] [Abstract][Full Text] [Related]
3. Bayesian genome-wide TWAS with reference transcriptomic data of brain and blood tissues identified 141 risk genes for Alzheimer's disease dementia.
Guo S; Yang J
Alzheimers Res Ther; 2024 Jun; 16(1):120. PubMed ID: 38824563
[TBL] [Abstract][Full Text] [Related]
4. Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping.
Kikuchi M; Hara N; Hasegawa M; Miyashita A; Kuwano R; Ikeuchi T; Nakaya A
BMC Med Genomics; 2019 Sep; 12(1):128. PubMed ID: 31500627
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic dissection of Alzheimer's disease pinpoints causal variants and reveals epigenome erosion.
Xiong X; James BT; Boix CA; Park YP; Galani K; Victor MB; Sun N; Hou L; Ho LL; Mantero J; Scannail AN; Dileep V; Dong W; Mathys H; Bennett DA; Tsai LH; Kellis M
Cell; 2023 Sep; 186(20):4422-4437.e21. PubMed ID: 37774680
[TBL] [Abstract][Full Text] [Related]
6. Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.
Andrews SJ; Fulton-Howard B; Goate A
Lancet Neurol; 2020 Apr; 19(4):326-335. PubMed ID: 31986256
[TBL] [Abstract][Full Text] [Related]
7. Data integration for functional annotation of regulatory single nucleotide polymorphisms associated with Alzheimer's disease susceptibility.
Amber S; Zahid S
Gene; 2018 Sep; 672():115-125. PubMed ID: 29883757
[TBL] [Abstract][Full Text] [Related]
8. Predicting regulatory variants using a dense epigenomic mapped CNN model elucidated the molecular basis of trait-tissue associations.
Pei G; Hu R; Dai Y; Manuel AM; Zhao Z; Jia P
Nucleic Acids Res; 2021 Jan; 49(1):53-66. PubMed ID: 33300042
[TBL] [Abstract][Full Text] [Related]
9. Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration.
Matoba N; Quiroga IY; Phanstiel DH; Won H
J Vis Exp; 2020 Jan; (155):. PubMed ID: 31984958
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide significant, replicated and functional risk variants for Alzheimer's disease.
Guo X; Qiu W; Garcia-Milian R; Lin X; Zhang Y; Cao Y; Tan Y; Wang Z; Shi J; Wang J; Liu D; Song L; Xu Y; Wang X; Liu N; Sun T; Zheng J; Luo J; Zhang H; Xu J; Kang L; Ma C; Wang K; Luo X
J Neural Transm (Vienna); 2017 Nov; 124(11):1455-1471. PubMed ID: 28770390
[TBL] [Abstract][Full Text] [Related]
11. Deep post-GWAS analysis identifies potential risk genes and risk variants for Alzheimer's disease, providing new insights into its disease mechanisms.
Wang Z; Zhang Q; Lin JR; Jabalameli MR; Mitra J; Nguyen N; Zhang ZD
Sci Rep; 2021 Oct; 11(1):20511. PubMed ID: 34654853
[TBL] [Abstract][Full Text] [Related]
12. A practical view of fine-mapping and gene prioritization in the post-genome-wide association era.
Broekema RV; Bakker OB; Jonkers IH
Open Biol; 2020 Jan; 10(1):190221. PubMed ID: 31937202
[TBL] [Abstract][Full Text] [Related]
13. Untangling Genetic Risk for Alzheimer's Disease.
Pimenova AA; Raj T; Goate AM
Biol Psychiatry; 2018 Feb; 83(4):300-310. PubMed ID: 28666525
[TBL] [Abstract][Full Text] [Related]
14. Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer's disease and Parkinson's disease: a large-scale multi-trait association analysis.
Guo P; Gong W; Li Y; Liu L; Yan R; Wang Y; Zhang Y; Yuan Z
BMC Med; 2022 Jun; 20(1):214. PubMed ID: 35729600
[TBL] [Abstract][Full Text] [Related]
15. An analysis of genetically regulated gene expression across multiple tissues implicates novel gene candidates in Alzheimer's disease.
Gerring ZF; Lupton MK; Edey D; Gamazon ER; Derks EM
Alzheimers Res Ther; 2020 Apr; 12(1):43. PubMed ID: 32299494
[TBL] [Abstract][Full Text] [Related]
16. Genomic variants, genes, and pathways of Alzheimer's disease: An overview.
Naj AC; Schellenberg GD;
Am J Med Genet B Neuropsychiatr Genet; 2017 Jan; 174(1):5-26. PubMed ID: 27943641
[TBL] [Abstract][Full Text] [Related]
17. Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease.
Lu Q; Powles RL; Abdallah S; Ou D; Wang Q; Hu Y; Lu Y; Liu W; Li B; Mukherjee S; Crane PK; Zhao H
PLoS Genet; 2017 Jul; 13(7):e1006933. PubMed ID: 28742084
[TBL] [Abstract][Full Text] [Related]
18. Genetic risk for Alzheimer's disease is concentrated in specific macrophage and microglial transcriptional networks.
Tansey KE; Cameron D; Hill MJ
Genome Med; 2018 Feb; 10(1):14. PubMed ID: 29482603
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal transcriptome-wide association study and neurobiological pathway analysis for Alzheimer's disease.
Liu N; Xu J; Liu H; Zhang S; Li M; Zhou Y; Qin W; Li MJ; Yu C;
PLoS Genet; 2021 Feb; 17(2):e1009363. PubMed ID: 33630843
[TBL] [Abstract][Full Text] [Related]
20. Genetics of Alzheimer's disease.
Chouraki V; Seshadri S
Adv Genet; 2014; 87():245-94. PubMed ID: 25311924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
